Примери за използване на Unacceptable toxicity на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Treatment continued until disease progression or unacceptable toxicity.
Patients were treated with pembrolizumab until unacceptable toxicity or disease progression.
It is recommended that treatment be continued until progression of the underlying disease or until unacceptable toxicity.
Treatment continues until disease progression, unacceptable toxicity, or patient withdrawal.
Patients continued therapy with Stivarga until clinical orradiological disease progression or unacceptable toxicity.
Treatment should continue as long as benefit is observed or until unacceptable toxicity occurs(see section 4.4).
Treatment should continue until the patient no longer derives benefit or the development of unacceptable toxicity.
It is recommended that treatment be continued until disease progression or unacceptable toxicity(see section 5.1, study MO22224).
Treatment should be continued as long as the patient does not show evidence of disease progression or unacceptable toxicity.
Patients received pembrolizumab at a dose of 200 mg every 3 weeks until unacceptable toxicity or disease progression.
A subsequent course of induction may be administered in patients who do not show disease progression or unacceptable toxicity.
Patients were treated until disease progression or unacceptable toxicity occurred.
Patients(n= 110) received 3.6 mg/kg of trastuzumab emtansine intravenously every 3 weeks until disease progression or unacceptable toxicity.
IMBRUVICA was administered until disease progression or unacceptable toxicity.
In the bevacizumab-containing arms, patients could receive bevacizumab as a single-agent every 3 weeks until disease progression or unacceptable toxicity.
Treatment was continued until radiological progression of the underlying disease, unacceptable toxicity or for up to 2 years.
The recommended dose of olaratumab is 15 mg/kg administered by intravenous infusion on days 1 and8 of each 3 week cycle until disease progression or unacceptable toxicity.
Patients should be treated until disease progression or unacceptable toxicity occurs.
Treatment was administered until disease progression or development of an unacceptable toxicity.
Treatment with vemurafenib should continue until disease progression or the development of unacceptable toxicity(see tables 1 and 2 below).
Patients should be treated with KEYTRUDA until disease progression or unacceptable toxicity.
Idelalisib was taken until disease progression or unacceptable toxicity.
Treatment was given until progressive disease or unacceptable toxicity.
Patients received treatment until disease progression or unacceptable toxicity.
Patients continued therapy until disease progression or unacceptable toxicity.
Treatment should be continued until disease progression or unacceptable toxicity.
Patients should be treated until disease progression or unacceptable toxicity.
Treatment should continue until disease progression or unacceptable toxicity.
Treatment with mogamulizumab continued until disease progression or unacceptable toxicity.
Treatment may be continued until disease progression or until unacceptable toxicity occurs.